SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001628280-17-003370
Filing Date
2017-04-05
Accepted
2017-04-05 15:06:08
Documents
3
Period of Report
2017-03-30
Items
Item 5.02: Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K ad-hoc8xk502901bonussevera.htm 8-K 44355
2 EXHIBIT 10.1 admsex101.htm EX-10.1 30897
3 admslogo.jpg GRAPHIC 10786
  Complete submission text file 0001628280-17-003370.txt   86136
Mailing Address 1900 POWELL ST., SUITE 750 EMERYVILLE CA 94608
Business Address 1900 POWELL ST., SUITE 750 EMERYVILLE CA 94608 510-450-3554
Adamas Pharmaceuticals Inc (Filer) CIK: 0001328143 (see all company filings)

IRS No.: 421560076 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-36399 | Film No.: 17742289
SIC: 2834 Pharmaceutical Preparations